Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

clinical_trials_2

Amneal’s IPX-203 shows promising results for motor fluctuations in Parkinson’s disease

September 8, 2021 Research and Development

Amneal Pharmaceuticals has recently announced that its product IPX-203 (carbidopa + levodopa, (CD/LD)) achieved key primary and secondary endpoints in …
News
cdc-un8tv9pw2ik-unsplash_1

COVID booster vaccines to get green light in “next few days”, according to health secretary

September 8, 2021 Research and Development

Coronavirus booster jabs are expected to be approved in “the next few days”, the UK Health Secretary, Sajid David, has …
News

STI rates remain at concerning level despite 2020 fall

September 8, 2021 Research and Development

New data from Public Health England (PHE) reveal that despite diagnoses of sexually transmitted infections (STIs) decreasing in 2020 by …
News
sanofi_hq__boetie_hall_web

Sanofi acquires Kadmon in $1.9 billion deal

September 8, 2021 Research and Development

Sanofi has announced that is has entered into a definitive merger agreement with Kadmon Holdings adding Rezurock (belumosudil) to its …
News

FDA halts BioMarin’s PKU gene therapy trial

September 7, 2021 Manufacturing and Production, Medical Communications, Research and Development

BioMarin Pharma has announced that the FDA has slapped a clinical hold on its Phase 1/2 trial of its candidate …
News

Vaginal ring could help prevent HIV infection in women

September 7, 2021 Manufacturing and Production, Research and Development

Researchers from the Kenya Medical Research Institute (KEMRI) are exploring the use of an intra vaginal ring containing anti-HIV medication …
News

Sinovac booster jab reverses antibody drop from Delta variant, study finds

September 6, 2021 Medical Communications, Research and Development, Sales and Marketing

Researchers have found that a booster shot of Sinovac’s COVID-19 vaccine reverses a decline in antibody activities against the Delta …
News
astrazeneca_sign_sky

AstraZeneca’s Ultomiris approved for use on children in EU

September 3, 2021 Medical Communications, Research and Development

AstraZeneca has gained EU approval for its rare blood disorder drug, Ultomiris, for use in children. The drug was developed …
News
andrei_r_-_shutterstock_1935537274_720

NICE and Cochrane to collaborate on living recommendations

September 1, 2021 Medical Communications, Research and Development

NICE has announced a collaboration with Cochrane, in which Cochrane will help deliver ‘living’ recommendations across the NICE guideline portfolio. …
News

Viper venom found to inhibit COVID virus from multiplying

September 1, 2021 Medical Communications, Research and Development

Brazilian researchers have found that a molecule in the venom of a jararacussu pit viper can prevent coronavirus reproduction. The …
News
annie-spratt-yiiz4olewg4-unsplash_1

AI test screens for COVID-19 26% faster than lateral flow tests

September 1, 2021 Research and Development

A University of Oxford-led study has shown that COVID-19 screening results were available 45 minutes after patients arrived in the …
News
moderna_norwood_plant

Fourth contaminated Moderna vial found in Japan

September 1, 2021 Medical Communications, Research and Development

A fourth contamination case in less than a week in Japan has been reported involving Moderna’s COVID-19 vaccine, which threatens …
News

NICE approves life-saving cholesterol drug for NHS

September 1, 2021 Research and Development

NICE has approved the ground-breaking cholesterol-lowering drug inclisiran, made by Novartis, for use on the NHS. This is an option …
News

Malaria sickness could be cut by 70%, study finds

August 26, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Researchers from the London School of Hygiene & Tropical Medicine (LSHTM) have found a new approach to protecting young African …
News

Trial planned to investigate ketamine in treatment-resistant depression

August 25, 2021 Research and Development

HMNC Brain Health and Develco Pharma have partnered to develop an investigational oral prolonged-release formulation of ketamine, targeting treatment-resistant depression …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025